- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2014
- Public Summary Document (PSD) March 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2014 PBAC Meeting - Word
Febuxostat – March 2014
Febuxostat, tablet, 80 mg and 120 mg, Adenuric®
Last updated
24 March 2015